115 related articles for article (PubMed ID: 7510241)
21. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
[TBL] [Abstract][Full Text] [Related]
22. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
Simpson KL; Jones A; Norman S; Holmes CH
Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage.
Venneker GT; van den Hoogen FH; Boerbooms AM; Bos JD; Asghar SS
Lab Invest; 1994 Jun; 70(6):830-5. PubMed ID: 7516986
[TBL] [Abstract][Full Text] [Related]
24. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
[TBL] [Abstract][Full Text] [Related]
25. Abnormal immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with AIDS.
Madi N; Steiger G; Estreicher J; Schifferli JA
J Immunol; 1992 Feb; 148(3):723-8. PubMed ID: 1530955
[TBL] [Abstract][Full Text] [Related]
26. Expression of complement system regulatory molecules in the endometrium of normal ovulatory and hyperstimulated women correlate with menstrual cycle phase.
Nogawa Fonzar-Marana RR; Ferriani RA; Soares SG; Cavalcante-Neto FF; Teixeira JE; Barbosa JE
Fertil Steril; 2006 Sep; 86(3):758-61. PubMed ID: 16831436
[TBL] [Abstract][Full Text] [Related]
27. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
[TBL] [Abstract][Full Text] [Related]
28. Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.
Nickells MW; Alvarez JI; Lublin DM; Atkinson JP
J Immunol; 1994 Jan; 152(2):676-85. PubMed ID: 7506731
[TBL] [Abstract][Full Text] [Related]
29. Acquired loss of erythrocyte complement receptor type 1 in patients with diabetic nephropathy undergoing hemodialysis.
Wakabayashi M; Ohi H; Tamano M; Onda K; Fujita T; Tomino Y
Nephron Exp Nephrol; 2006; 104(3):e89-95. PubMed ID: 16837818
[TBL] [Abstract][Full Text] [Related]
30. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I
Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603
[TBL] [Abstract][Full Text] [Related]
31. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
32. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
Terstappen LW; Nguyen M; Lazarus HM; Medof ME
J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
[TBL] [Abstract][Full Text] [Related]
33. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
Craig ML; Waitumbi JN; Taylor RP
J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
[TBL] [Abstract][Full Text] [Related]
34. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry.
Fujioka S; Yamada T
Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090
[TBL] [Abstract][Full Text] [Related]
35. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
36. Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35): vesiculation and/or proteolysis?
Dervillez X; Oudin S; Libyh MT; Tabary T; Reveil B; Philbert F; Bougy F; Pluot M; Cohen JH
Immunopharmacology; 1997 Dec; 38(1-2):129-40. PubMed ID: 9476124
[TBL] [Abstract][Full Text] [Related]
37. Reduction in erythrocyte complement receptor 1 (CR1, CD35) and decay accelerating factor (DAF, CD55) during normal pregnancy.
Imrie HJ; McGonigle TP; Liu DT; Jones DR
J Reprod Immunol; 1996 Oct; 31(3):221-7. PubMed ID: 8905554
[TBL] [Abstract][Full Text] [Related]
38. [Complement regulatory proteins CR 1, MCP, DAF, and MACIF levels in patients with Behçet's disease].
Kure T; Kogure M
Nippon Ganka Gakkai Zasshi; 1996 May; 100(5):376-80. PubMed ID: 8651056
[TBL] [Abstract][Full Text] [Related]
39. Loss of complement receptor type 1 (CR1) on ageing of erythrocytes. Studies of proteolytic release of the receptor.
Ripoche J; Sim RB
Biochem J; 1986 May; 235(3):815-21. PubMed ID: 2944510
[TBL] [Abstract][Full Text] [Related]
40. Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitro.
Shapiro S; Kohn D; Miller B; Gershon H
Clin Exp Immunol; 1994 Jan; 95(1):181-90. PubMed ID: 8287603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
